In silico molecular docking of selected polyphenols against interleukin-17A target in gouty arthritis

The binding of Interleukin-17A (IL-17A) to its receptor causes the release of chemokine which have an implication in the pathogenesis of gouty arthritis. Though, some synthetic drugs have been proved worthy as IL-17A inhibitors in the management of gout but they have been associated with a number o...

Full description

Bibliographic Details
Main Authors: Haruna Isiyaku Umar, Adeola Ajayi, Sunday Solomon Josiah, Tolulope Saliu, Jamilu Bala Danjuma, Prosper Obed Chukwuemeka
Format: Article
Language:English
Published: TMKarpinski Publisher, Tomasz M. Karpiński 2020-10-01
Series:European Journal of Biological Research
Subjects:
Online Access:http://www.journals.tmkarpinski.com/index.php/ejbr/article/view/341